Annual report pursuant to Section 13 and 15(d)

Summary of Significant Accounting Policies - Schedule of Common Stock Equivalents Excluded from the Calculation of Diluted Net Loss Per Share (Details)

v3.24.1
Summary of Significant Accounting Policies - Schedule of Common Stock Equivalents Excluded from the Calculation of Diluted Net Loss Per Share (Details) - shares
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Anti-dilutive securities    
Total shares excluded from diluted net loss per share applicable to common stockholders 17,397,554 17,074,046
Employee Stock Option    
Anti-dilutive securities    
Total shares excluded from diluted net loss per share applicable to common stockholders 1,548,642 1,727,327
Unvested Restricted Stock Units    
Anti-dilutive securities    
Total shares excluded from diluted net loss per share applicable to common stockholders 1,706,614 1,204,421
Warrants    
Anti-dilutive securities    
Total shares excluded from diluted net loss per share applicable to common stockholders 14,142,298 14,142,298